Infections: News and Research on Mycoses

MeSH tree: C01.150.703

FDA approves Dupixent for allergic fungal rhinosinusitis

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis (AFRS) and a history of sino-nasal surgery.

Antifungal resistance is making thrush hard to treat. Here's why

Thrush is one of the most common infections in the world. It's caused by the fungi Candida—specifically, the yeast Candida albicans. Although yeast infections are normally treated easily with antifungal drugs, a growing number ...

page 2 from 14